These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 665710

  • 1. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test.
    Reschini E, Giustina G.
    Am J Med Sci; 1978; 275(1):33-42. PubMed ID: 665710
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP, Thomopoulos P.
    Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
    Nishida S, Matsumura S, Horino M, Oyama H, Tenku A.
    Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
    [Abstract] [Full Text] [Related]

  • 10. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L.
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [Abstract] [Full Text] [Related]

  • 11. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 18. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome.
    Fok AC, Tan KT, Jacob E, Sum CF.
    Steroids; 1991 Nov; 56(11):549-51. PubMed ID: 1814020
    [Abstract] [Full Text] [Related]

  • 19. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA, Cutler GB, Chrousos GP, Nieman LK.
    JAMA; 1993 May 05; 269(17):2232-8. PubMed ID: 8386285
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.